Oncology Billing · Part B Drug Wastage

JW vs JZ in 2026: the wastage call auditors now expect on every single-dose vial

One modifier says you wasted nothing. The other reports exactly what hit the sharps container. Getting it wrong no longer means a soft denial. It feeds the federal discarded-drug refund program, and that is where 2026 audits are pointing.

The short answer: on every separately payable single-dose vial or single-use package, you must append JZ when the full amount was given and nothing was discarded, or JW on a separate line for the discarded units. Multi-dose vials get neither. There is no third option and no blank allowed.

Attestation of zero waste JZ

Nothing was discarded

The entire single-dose vial was administered, or the billed units exactly match what the patient received. JZ is your on-the-record statement that no payable drug went to waste.

Report of discarded drug JW

Some was discarded

A portion of the single-dose vial could not be used for that patient and was not usable for another. The discarded units go on their own line with JW, alongside the administered line.

The unique angle

The single-dose vial decision matrix

Same drug, same clinic, different scenario. The trigger for JZ versus JW is not the drug, it is what happened to the vial. Here is how the common oncology-infusion situations split.

Scenario at the chair

JZ — no waste

JW — discarded amount

Full single-dose vial given, dose equals vial size

Use JZ. Billed units = administered units, zero remainder.

Not applicable. No units left to discard.

Weight-based dose smaller than the vial, remainder tossed

No. A payable portion was discarded.

Use JW on a separate line for the discarded units; administered units on the primary line.

Dose spans multiple vials, last vial fully drawn

Use JZ. If the whole quantity across vials was administered with no remainder.

Only if the final vial left an unused, discarded portion.

Multi-dose vial, later doses drawn for other patients

No modifier. JW and JZ do not apply to multi-dose vials.

No modifier. Remaining volume is not "discarded" drug.

Drug packaged under the OPPS per-day threshold (status N)

Generally no. JZ/JW attach to separately payable drugs, not packaged ones.

Generally no. No separate payment means no separate wastage line.

Vial dropped, contaminated, or spoiled before administration

No. Nothing reached the patient.

Not billable as JW. CMS wastage rules cover the discarded remainder of an administered vial, not spoilage. Document per payer waste policy.

The one that trips coders: a blank is not a valid answer anymore. For separately payable single-dose container drugs, a claim line with neither JZ nor JW is the pattern edits and auditors flag first. Every eligible line needs one or the other.

Documentation that holds up

What each modifier has to be backed by

The modifier is the claim-side signal. The chart is what defends it. Because JW-reported units now feed manufacturer refund calculations, the medical record standard for wastage is higher than it was two years ago.

JZ Zero-waste attestation keep it clean, keep it reconcilable

Ordered dose and administered dose match the billed units, with no remainder
NDC and vial/package size recorded so units reconcile to the container
MAR shows the full amount given to the patient
No wastage entry anywhere in the encounter that would contradict "no discard"
Unit rounding to the nearest billable increment is consistent with the dose

JW Discarded-drug report the amount, the reason, the calculation

Exact discarded amount, with administered and wasted units broken out
Weight or BSA-based dose calculation showing why a remainder existed
Statement that the discarded portion was not usable for another patient
Wastage documented in the MAR/waste log at the time it occurred, ideally witnessed
Discarded units billed on a separate claim line with JW; administered units on the primary line
NDC and single-dose container size that make the total (given + wasted) tie back to whole vials

Why this got sharper in 2026

Your JW line is now a federal refund input

The discarded-drug refund program means CMS uses JW-reported quantities to bill manufacturers for waste on certain single-dose container drugs. Over-reporting inflates the picture; under-reporting or a missing JZ breaks the audit trail. That is the audit lens for 2026.

Vial administered

Nurse gives the dose and documents any remainder in real time.

Modifier decided

JZ for zero waste, JW plus a separate line for the discarded units.

Claim adjudicated

Edits confirm every eligible single-dose line carries JZ or JW.

Refund reconciled

CMS aggregates JW units for manufacturer refund reporting.

The 2026 guidance this is built on

CMS JW modifier policyDiscarded/unused amount of a single-dose vial or single-use package reported on a separate line. In effect nationally since January 1, 2017.

CMS JZ modifier policyAttests no discarded amount for single-dose container drugs. Required since July 1, 2023 and enforced through claim edits.

Medicare Claims Processing Manual, Ch. 17, §40The discarded drugs and biologicals instructions governing single-dose vial billing and unit reporting.

Discarded Drug Refund, CAA 2021 §90004Manufacturer refunds for discarded amounts of certain single-dose container drugs, calculated from JW-reported units.

CY2026 OPPS/ASC Final RuleSeparately payable drugs (status indicator K) above the per-day packaging threshold; packaged drugs (status N) fall outside JW/JZ.

CY2026 Medicare Physician Fee ScheduleASP-based Part B drug payment framework that JZ/JW attach to on the physician-office side.

Wastage coding should not be the thing that costs you a clean claim rate

ASP-RCM Solutions builds JZ/JW logic into oncology billing at the point of coding, reconciles wasted units against vial size, and keeps the documentation an auditor asks for attached to the line. Fewer edits, defensible JW reporting, no missing modifiers.

Talk to our oncology billing team